ZBIO — Zenas BioPharma, Inc. Common Stock · rev $10.0M

Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.

Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.

Use this ZBIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ZBIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ZBIO SEC filings page. Lician reads the product cache first so this HTML stays unique to Zenas BioPharma, Inc. Common Stock even when a live quote feed is slow.